MX2024007070A - Alz-801 para uso en el tratamiento de la enfermedad de alzheimer. - Google Patents
Alz-801 para uso en el tratamiento de la enfermedad de alzheimer.Info
- Publication number
- MX2024007070A MX2024007070A MX2024007070A MX2024007070A MX2024007070A MX 2024007070 A MX2024007070 A MX 2024007070A MX 2024007070 A MX2024007070 A MX 2024007070A MX 2024007070 A MX2024007070 A MX 2024007070A MX 2024007070 A MX2024007070 A MX 2024007070A
- Authority
- MX
- Mexico
- Prior art keywords
- alz
- disease
- treating alzheimer
- alzheimer
- treating
- Prior art date
Links
- NRZRFNYKMSAZBI-ZETCQYMHSA-N 3-[[(2s)-2-amino-3-methylbutanoyl]amino]propane-1-sulfonic acid Chemical compound CC(C)[C@H](N)C(=O)NCCCS(O)(=O)=O NRZRFNYKMSAZBI-ZETCQYMHSA-N 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287552P | 2021-12-09 | 2021-12-09 | |
| PCT/US2022/052331 WO2023107658A1 (en) | 2021-12-09 | 2022-12-09 | Alz-801 for use in treating alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007070A true MX2024007070A (es) | 2024-08-22 |
Family
ID=85157530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007070A MX2024007070A (es) | 2021-12-09 | 2022-12-09 | Alz-801 para uso en el tratamiento de la enfermedad de alzheimer. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250041248A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4444286A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542844A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240116529A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118678950A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022405026A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3240392A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313404A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007070A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023107658A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3347002B1 (en) * | 2015-09-10 | 2023-06-07 | Alzheon, Inc. | Treatment of alzheimer's disease in a particular patient population |
| MX2021001287A (es) * | 2018-08-01 | 2021-07-15 | Alzheon Inc | Métodos para tratar trastornos neurodegenerativos. |
-
2022
- 2022-12-09 AU AU2022405026A patent/AU2022405026A1/en active Pending
- 2022-12-09 EP EP22851094.7A patent/EP4444286A1/en active Pending
- 2022-12-09 IL IL313404A patent/IL313404A/en unknown
- 2022-12-09 WO PCT/US2022/052331 patent/WO2023107658A1/en not_active Ceased
- 2022-12-09 MX MX2024007070A patent/MX2024007070A/es unknown
- 2022-12-09 CA CA3240392A patent/CA3240392A1/en active Pending
- 2022-12-09 JP JP2024534268A patent/JP2024542844A/ja active Pending
- 2022-12-09 US US18/717,139 patent/US20250041248A1/en active Pending
- 2022-12-09 CN CN202280091217.0A patent/CN118678950A/zh active Pending
- 2022-12-09 KR KR1020247022383A patent/KR20240116529A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4444286A1 (en) | 2024-10-16 |
| JP2024542844A (ja) | 2024-11-15 |
| AU2022405026A1 (en) | 2024-06-20 |
| KR20240116529A (ko) | 2024-07-29 |
| IL313404A (en) | 2024-08-01 |
| WO2023107658A1 (en) | 2023-06-15 |
| US20250041248A1 (en) | 2025-02-06 |
| CN118678950A (zh) | 2024-09-20 |
| CA3240392A1 (en) | 2023-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021001575A1 (es) | Pirazolopirimidinas sustituidas y purinas sustituidas y su uso como inhibidores de proteasa procesadora específica de ubiquitina 1 (usp1) | |
| BR112022016382A2 (pt) | Triptaminas específicas para o uso no tratamento de doenças do humor | |
| CL2024001022A1 (es) | Moléculas pequeñas para el tratamiento del cáncer | |
| CO2019007810A2 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| CO2020015758A2 (es) | Compuestos de purinona y su uso en el tratamiento del cáncer | |
| MX2020009602A (es) | Formulaciones de pulverizacion de epinefrina. | |
| EA202092154A1 (ru) | Комбинированная терапия | |
| BR112022007595A2 (pt) | Métodos para tratar doença de alzheimer | |
| MX378579B (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| CR20190361A (es) | Dendrímeros terapéuticos | |
| EA202190308A1 (ru) | Применение пролекарств рилузола для лечения болезни альцгеймера | |
| MX2022010693A (es) | Compuestos, composiciones y metodos para inhibidores de la proteina quinasa que interactua con el receptor i para el tratamiento de enfermedades. | |
| CL2024000867A1 (es) | Compuestos de imidazopiridazina inhibidores de il-17. | |
| MX2023004156A (es) | Terapia combinada para el tratamiento del cancer. | |
| CO2022010592A2 (es) | Métodos de tratamiento de la esplenomegalia | |
| EA202091112A1 (ru) | Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение | |
| MX382357B (es) | Métodos y composiciones para tratar infecciones fúngicas cutáneas. | |
| CY1116234T1 (el) | Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
| MX2021007330A (es) | Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia. | |
| CL2021000269A1 (es) | Métodos para tratar trastornos neurodegenerativos | |
| MX2022000082A (es) | Composiciones terapeuticas y metodos para tratar canceres. | |
| JOP20230173A1 (ar) | أشطر إطالة العمر-النصفي وطرق استخدامها | |
| MX2023010918A (es) | Metodos y composiciones para el tratamiento de enfermedades oculares. | |
| BR112019007214A2 (pt) | composições do apilimode e métodos para uso do mesmo no tratamento do mal de alzheimer | |
| BR112022025128A2 (pt) | Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae |